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Summary
Ionophoric polyethers are produced by the exquisitely
stereoselective oxidative cyclization of a linear polyke-
tide, probably via a triepoxide intermediate. We report
here that deletion of either or both of the monBI and
monBII genes from the monensin biosynthetic gene
cluster gave strains that produced, in place of monen-
sinsA andB, amixture of C-3-demethylmonensins and
a number of minor components, including C-9-epi-
monensinA. All theminor componentswere efficiently
converted into monensins by subsequent acid treat-
ment. These data strongly suggest that epoxide ring
opening and concomitant polyether ring formation
are catalyzed by the MonB enzymes, rather than by
the enzyme MonCII as previously thought. Consistent
with this, homologymodeling shows that the structure
of MonB-type enzymes closely resembles the recently
determined structure of limonene-1,2-epoxide hydro-
lase from Rhodococcus erythropolis.
Introduction
Cyclic polyethers represent an important and extensive
family of polyketide natural products. These include
a large number of polyether antibiotics [1], as well as
highly elaborate marine toxins, such as brevetoxin [2]
and maitotoxin [3]. Monensins A and B are typical poly-
ether antibiotics, acting as specific ionophores to dissi-
pate ionic gradients across cell membranes [4]. As early
as 1974, Westley proposed that the polyether tetrahy-
drofuran and tetrahydropyran rings were formed by
the sequential opening of a polyepoxide precursor [5].
On the basis of later experiments with labeled precur-
sors, the biosynthesis of monensins was accordingly
proposed to involve the intermediacy of a linear E-, E-,
E-polyketide triene [6], which is stereospecifically epox-
idized to a triepoxide. The triepoxide then undergoes
a cascade of SN2 epoxide openings to give a unique pol-
yether product (Figure 1). An alternative mechanistic
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oxetane intermediates, starting from a Z-, Z-, Z-triene
[7]. More recently, information from the sequencing of
the monensin [8, 9] and nanchangmycin [10] biosyn-
thetic gene clusters has given support to the main out-
lines of the triepoxide hypothesis. Each cluster contains
genes encoding a non-haem, flavin-dependent mono-
oxygenase (monCI and nanO) and an enzyme displaying
homology to authentic epoxide hydrolases (monCII and
nanE) that could function as the key epoxide-opening
cyclase enzyme [8–10]. Two novel genes (monBI and
monBII), whose products show significant sequence
similarity to known D5-3-ketosteroid isomerases [11],
were also found in the monensin cluster. This prompted
the suggestion [8, 9] that the products of these genes
might isomerize two trisubstituted double bonds on
the growing polyketide chain in order to produce a Z-,
Z-, E-triene intermediate that could also undergo stereo-
specific epoxidation and ring opening to monensin. The
counterpart in nanchangmycin biosynthesis is the inter-
nally duplicated nanI gene that appears to comprise
monBI and monBII homologs fused head to tail [10].
This suggested role for MonB and NanI proteins has
however been undermined by our recent finding that
a mutant of the monensin-producing strain of Strepto-
myces cinnamonensis, in which monCI has been de-
leted, accumulates a triene shunt metabolite that has
the E-, E-, E- configuration exclusively [12]. Meanwhile,
other recent work in our laboratory has shown that the
enzyme originally thought to function as the key epoxide
hydrolase/cyclase (MonCII) is likely to be involved in
polyketide chain release [13]. This has prompted us to
reexamine the role of the MonB proteins, and especially
their possible function as epoxide hydrolases/cyclases.
Results and Discussion
MonBI as a Putative Epoxide Hydrolase and Member
of the Adaptable a + b Barrel Fold Superfamily
Comparison of the MonB and NanI proteins to proteins
in the PDB database by using the program FUGUE [14]
readily identified their striking similarity to an emerging
family of proteins sharing the same fold but having di-
verse catalytic or binding activities. The archetype of
this family is scytalone dehydratase, which catalyzes
key steps in the fungal synthesis of melanin, involving
a-proton abstraction, leading to elimination of water
and aromatization [15]. Other prominent members in-
clude the following enzymes whose crystal structures
have also been determined to high resolution: limo-
nene-1,2-epoxide hydrolase from Rhodococcus eryth-
ropolis (PDB entry 1NWW, 1.2 A˚) [16]; the polyketide
cyclase SnoaL from Streptomyces nogalater (PDB entry
1SJW, 1.3 A˚), which catalyzes intramolecular aldol con-
densation in the closure of the A ring of the anthracycline
antibiotic nogalamycin [17]; and D5-3-ketosteroid isom-
erase from Pseudomonas putida (PDB entry 1OPY, 1.9
A˚) [18]. Analysis of the superimposed 3D structures of
1NWW, 1SJW, and 1OPY with DALI (http://www.ebi.
ac.uk/dali/) [19] reveals a highly conserved fold, with
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(between 1OPY and 1SJW) and 2.0 A˚ (between 1NWW
and 1OPY). The closest structural template for MonBI
and MonBII is the limonene epoxide hydrolase from
R. erythropolis [16], and the alignment of its sequence
with those of the MonB and NanI proteins clearly shows
the high conservation of secondary structural elements
(Figure 2A). The 3D model generated for MonBI corre-
sponds to a single domain that has been dubbed the
adaptable a + b barrel fold [20]. The close superimposi-
tion of the modeled structure on the template is shown in
Figure 2B. The a + b barrel fold comprises a curved, six-
stranded mixed b sheet, with four a helices packed onto
it to create a barrel-like structure housing a conical
pocket open at its larger end. Most residues lining this
pocket are hydrophobic, as in the other proteins of this
family. In all other proteins of the family, the pocket con-
tains the active site, and a number of polar amino acid
residues are present here and play a role in catalysis.
For example, as shown in Figure 2C, the active site of
limonene epoxide hydrolase contains two aspartate res-
idues, one (D101) acting as a general acid to promote
opening of the epoxide ring, and the other (D132) acting
as a general base to assist the nucleophilic attack of
a water molecule. A tyrosine residue (Y53) is also pro-
posed to participate as a general base. Likewise, for
the ketosteroid isomerases [11, 18], a conserved as-
partic acid (corresponding to D37 in MonBI; Figure 2A)
is the key general base that abstracts the proton from
the substrate. The MonB and NanI proteins do not share
conserved active site residues with any of the previously
studied proteins of this superfamily. However, between
MonBI, MonBII, and the domains NanIa and NanIb, there
Figure 1. Proposed Mechanism for Monensin Biosynthesis Involv-
ing Stereospecific Ring Opening of a Triepoxide Formed from an
E-, E-, E-Triene Precursorare a number of wholly conserved polar residues, in-
cluding ones (for example, E36 and E64) that are pre-
dicted to lie deep within the hydrophobic pocket (Fig-
ure 3B) and that are plausible candidates as active site
residues involved in acid-base catalysis. Although
such ideas require experimental testing, this detailed
analysis serves to confirm that the inferred structure of
the MonB and NanI proteins is compatible with the pro-
posal made here: that they function as epoxide hydro-
lases akin to limonene epoxide hydrolase.
Small-Angle X-Ray Scattering Confirms a Dimeric
Structure for MonBI
The quaternary structure of the members of the adapt-
able a + b barrel fold family is highly variable, ranging
from dimeric (limonene epoxide hydrolase [16], D5-3-
ketosteroid isomerase [18]) to trimeric (scytalone dehy-
dratase [15]), tetrameric (SnoaL [17]), and even tetra-
decameric (a subunit of calmodulin-dependent kinase
II [21]). The MonBI protein was initially modeled as a ho-
modimer based on its similarity with limonene epoxide
hydrolase (1NWW). The two monomers of the symmetri-
cal dimer pack against each other via hydrophobic and
electrostatic interactions that involve the side chains
of residues on the ‘‘back face’’ of the b sheet. A similar
dimeric interface has been observed in the crystal struc-
tures of 3-oxo-D5-steroid isomerase (1OPY) and limo-
nene epoxide hydrolase (1NWW). It is also found in the
polyketide cyclase SnoaL (1SJW), which is organized
as a dimer of dimers.
Expression and purification of histidine-tagged
MonBI protein from recombinant Escherichia coli (see
Experimental Procedures) allowed direct estimation of
its molecular mass and analysis of its quaternary struc-
ture. As judged by gel filtration (data not shown), the pro-
tein appeared dimeric. Small-angle X-ray scattering
(SAXS) was then carried out on MonBI in solution to con-
firm its oligomeric structure and to probe its overall size
and shape [22]. Shape reconstruction from these data
showed an excellent fit of the experimentally determined
electron density envelope of the protein to that pre-
dicted on the basis of the homology model (Figure 3A
and Supplemental Data available with this article online).
Deletion of the monB Genes
In-frame deletion mutants deficient in one or both of the
monB genes of S. cinnamonensis were produced as de-
scribed previously [9]. Each of the mutants (ABDBI and
ABDBII and the double mutant ABDBIBII) was fermented
in monensin production medium, and extracts were an-
alyzed by LC-MS and compared to those from wild-type
S. cinnamonensis. The LC-MS profiles of the mutants
appeared to be identical in each case and very different
from wild-type (Supplemental Data). No trace of either
monensin A (retention time of 17 min) or monensin B (re-
tention time of 15 min) was found, confirming that the
monB genes are essential for monensin production [9],
but also extending that analysis to show the presence,
as major products of all three mutants, of the C3-de-
methyl analogs of monensin A and B, at about 5% of
the levels of monensins normally seen in wild-type ex-
tracts. Numerous minor components were also present,
eluting with retention times between 3 and 10 min under
these conditions (see Supplemental Data).
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455Figure 2. Homology of MonBI and MonBII to
Limonene Epoxide Hydrolase
(A) Amino acid sequence alignment of
MonBI and MonBII from Streptomyces cin-
namonensis [8, 9], Nan1A and Nan1B (the
N- and C-terminal halves of NanI, respec-
tively) from Streptomyces nanchangensis
[10], and limonene-1,2-epoxide hydrolase
from Rhodococcus erythropolis (LEH) (PDB
entry 1NWW) [16]. Secondary structural ele-
ments of LEH are shown in EScript format
(http://escript.ibcp.fr/EScript/cgi-bin/EScript.
cgi).
(B) Superposition of the modeled structure of
MonBI and the crystal structure of LEH
(INWW). For clarity, only one protomer each
of MonB1 and of LEH is shown, although
both proteins are dimers in solution (see the
text).
(C) Proposed reaction mechanism of the LEH-
catalyzed reaction (redrawn from [16]).Isolation and Characterization of epi-Monensin A
In order to facilitate the isolation of minor metabolites,
the monBII gene was deleted in a monensin-overpro-
ducing industrial strain of S. cinnamonensis exactly as
for wild-type. From the fermentation extracts of this
strain, a metabolite was obtained with the same accu-
rate molecular mass as monensin A, but with a retention
time of 16 min (i.e., about 1 min earlier than monensin A).
NMR analysis, including 1H-NMR NOESY data (Supple-
mental Data), suggested that this monensin isomer is
the C-9-epimer, epi-monensin A. This metabolite, whichis not present in wild-type S. cinnamonensis cultures,
differs from monensin A only in the stereochemistry of
the spiroketal center. The fragmentation of the metabo-
lite in electrospray MSMS also differed characteristically
from that of monensin A [23].
Spiroketals epimerize under acidic conditions to the
more thermodynamically favored configuration [24].
We thus predicted that our putative C-9-epimer should
revert to authentic monensin A and confirm our interpre-
tation of the NMR data. Treatment of epi-monensin A
with HF [25] did indeed result in complete conversionFigure 3. Model of MonBI Highlighting Residues that May Be Important for Catalysis
(A) Shape reconstruction of dimeric MonBI. The experimental electron envelope for this protein, derived from measurement of small-angle
X-ray scattering in solution (SAXS) (see Supplemental Data), together with the 3D structure of MonBI generated by comparative modeling,
is displayed by using the program PyMol [41]. In each protomer, two conserved, buried polar residues potentially involved in catalysis, E36
and E64, are highlighted in red.
(B) Electrostatic surface representation of a MonBI protomer showing the location of E36 and E64 inside the hydrophobic cavity.
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novel metabolite, the C-26-deoxy analog of epi-monen-
sin A, was also isolated from the fermentation extracts of
the mutant and eluted with a retention time of 20 min
(data not shown). This compound was also readily con-
verted into C-26-deoxymonensin A by treatment with
HF. It appears that C-26-deoxy-epi-monensin A is a
poor substrate for MonE, the cytochrome P450 hydrox-
ylase that is responsible for hydroxylation of the terminal
C-26 position [8, 9].
Nonenzymatic Cyclization to Form Monensins
If MonBI and MonBII have been correctly identified as
the enzymes that control the conversion of a triepoxide
intermediate, probably protein-bound, into a polyether,
then in their absence such intermediates should accu-
mulate. The products seen in fermentation extracts of
monB mutants ought then to reflect a balance between
the chemical degradation of such species, their chemi-
cal or enzymatic release if they are protein bound, and
the specificity of the C-3-O-methyltransferase and
C-26-hydroxylase enzymes that are present as part of
the monensin biosynthetic pathway. The observation
that C-3-O-demethylmonensins A and B are the major
products from all monB mutant strains shows, first,
that epoxide ring opening and formation of the polyether
rings with the correct regio- and stereospecificity is
a chemically favored process under these conditions.
Second, it shows that O-methylation at C-3 occurs ei-
ther before polyether ring formation or before release
of the monensin product from a protein, or both. Further,
it seems that in the absence of methylation at C-3-OH,
nucleophilic attack by the C-5 hydroxyl group on the
C-9 carbonyl takes place preferentially to form the natu-
ral epimer of the spiroketal. This nonenzymatic kinetic
control means that the subsequent cyclization gives
C-3-O-demethylmonensins with the correct configura-
tion (Figure 4).
Once the A ring has formed (Figure 4), the resulting
hemiacetal hydroxyl opens the first epoxide to form
the B ring, by nucleophilic attack at the more hindered
carbon and with inversion at this center. This chemical
preference can be rationalized on the basis that the
alternative attack at the less hindered carbon would be
a kinetically disfavored 6-endo-tet cyclization in viola-
tion of Baldwin’s rules [26]. Also, inversion at the tertiary
center can be understood if acid catalysis promotes sig-
nificant opening of the epoxide in the transition state, al-
lowing the developing carbocation to be captured by the
incoming hydroxyl nucleophile. This ‘‘loose SN2’’ mech-
anism avoids the sterically disfavored SN2 mechanism,
while ensuring stereochemical inversion. Such a mecha-
nism has been exploited in the construction of synthetic
cyclic polyethers [27, 28]. It is also the basis of the mech-
anism proposed for limonene epoxide hydrolase [16]
(Figure 3C). The same principles would apply to sub-
sequent closure of the C ring of monensin (Figure 4). For-
mation of the D ring also involves a favorable exo-tetSN2
ring closure, and the final reversible hemiacetal ring clo-
sure would be expected to give the natural configuration
as the thermodynamically favored product.
The isolation of epi-monensins A and B and of C-26-
deoxy-epi-monensins A and B as minor products from
strains mutant in either or both of the monB genesreveals a second alternative (minor) fate for putative
triepoxide intermediates, in the absence of MonB pro-
teins. If the C3-hydroxy is methylated in the tri-epoxide
intermediate, the unnatural spiroketal epimer appears
to be kinetically favored, leading to the epi-isomer.
Cyclization Intermediates from MonB-Deficient
Strains Are Chemically Competent
for Conversion into Monensins
The nature of the faster-eluting, more polar metabolites
noted earlier as minor components in the LC-MS analy-
sis of the monB mutants is crucial for our proposal that
the MonB enzymes govern polyether ring formation
from the putative triepoxide. These species have molec-
ular ions coincident with those of monensin A (693.5),
monensin B and demethylmonensin A (679.5), and de-
methylmonensin B (665.5), but they are present in quan-
tities too small to allow direct structural determination
as yet. We reasoned that if these minor components rep-
resented species at the correct oxidation state but in-
completely cyclized (Figure 5), then their cyclization
should be accelerated by acid catalysis. The minor com-
ponents were purified by HPLC, pooled, and treated
with HF. Complete conversion of the material with mo-
lecular ion 679.5 to authentic C-3-O-demethyl monensin
A and monensin B was observed (Figure 6). Similarly, the
components with molecular ion 693.5 shifted to coelute
Figure 4. Modes of A Ring Closure Leading to Monensin A and
C-9-epi-Monensin
The unnatural epimer results from nucleophilic attack at the oppo-
site face of the C-9-carbonyl group to form the A ring hemiacetal.
This alternative configuration is trapped as the spiroketal as the
B ring is closed. 1H-NOESY correlations are indicated by double-
headed arrows. Protons are omitted for clarity.
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665.5 shifted to coelute with authentic C-3-O-demethyl
monensin B (data not shown). These results give strong
support to the identification of the MonB enzymes as ep-
oxide hydrolases involved in polyether ring formation. It
shows, first, that C-26-hydroxylation can occur before
either methylation or polyether ring formation. Second,
it shows that monB genes are clearly not required for
the formation of intermediate species that appear to
have the correct geometry and to be at the correct oxi-
dation level to give rise to monensins by ring opening/
cyclization. The presence of MonB enzymes apparently
accelerates, but does not change, the stereochemical
course of polyether ring formation, compared to the
acid-catalyzed process. Control of the spiroketal center
by the MonB proteins could be achieved if the relevant
MonB epoxide hydrolase is highly specific [29] and ac-
cepts only one epimer of the A ring hemiacetal.
Figure 5. Proposed Intermediates in the Nonenzymatic Cyclization
of a Triepoxide Metabolite Obtained When Monensin Biosynthesis
Is Blocked by Mutation in One or More monB GenesMonB-Type Enzymes as Epoxide Hydrolases
Involved in Polyether Ring Formation
The product of the genemonCII, previously proposed as
governing epoxide ring opening in monensin biosynthe-
sis, shows significant sequence and structural similarity,
over about 260 amino acids, to the epoxide hydrolases
of the a,b hydrolase family [30]. However, closer exami-
nation has revealed that the active site nucleophile in
MonCII would be a serine residue rather than the con-
served aspartate residue of this family; thus, the normal
acyl intermediate would be replaced in MonCII by a
much more stable ether intermediate. Also, few of these
epoxidases are known to hydrolyze trisubstituted epox-
ides, in contrast to the limonene epoxide hydrolase [18].
As will be discussed elsewhere [13], we have reassigned
MonCII as a thioesterase required for release of protein
bound intermediates in monensin biosynthesis.
Since neither MonBI nor MonBII can support monen-
sin biosynthesis on its own, the respective roles of
MonBI and MonBII in catalyzing the successive forma-
tion of the polyether rings in monensin remain to be de-
termined. The pattern of products in MonBI- and MonBII-
deficient mutants appears to be identical, which argues
that their actions are somehow coordinated. The protein
NanI, involved in nanchangmycin biosynthesis, carries
homologs of MonBI and MonBII in, respectively, its N-
terminal and C-terminal halves [10] (Figure 2A). Further
homology modeling (data not shown) suggests that
MonBI and MonBII could, in principle, exist as a hetero-
dimer in S. cinnamonensis. Whatever the protein ar-
rangement turns out to be, from the present results it is
clear that each ring closure in polyether formation oc-
curs stepwise in a definite order, under enzymatic con-
trol of one or more MonB-type enzymes.
This model can be extended to the biosynthesis of
much more complex polyethers, such as brevetoxin.
As has been previously pointed out [31], if the stepwise
or cascade opening of a polyepoxide is invoked [32] to
explain the biosynthesis of this marine toxin, it must
Figure 6. Acid-Catalyzed Cyclization of Putative Intermediate Spe-
cies in Monensin Biosynthesis
Cyclization intermediates having the same mass as monensin B
and demethylmonensin A (m/z, 679.5), but eluting earlier during
chromatography, were separated by LC-MS. Upon treatment with
HF, these intermediates cyclized to both demethylmonensin A
(ca. 12 min) and monensin B (ca. 14 min). The vertical scales of
the LC-MS traces are not identical.
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each kinetically disfavored and in violation of Baldwin’s
rules. It is thus highly unlikely that a spontaneous, non-
enzymatic cascade of epoxide openings is occurring
here. A stepwise mechanism, as proposed for monensin
cyclization, is much more attractive (see Figure 7). Suc-
cessive closure of each ring by a highly specific epoxide
hydrolase would present the substrate for the next ep-
oxide hydrolase. In this case, each substrate is stereo-
chemically identical, so only one MonB-like enzyme
might be required to carry out all nine cyclizations.
Significance
Monensin is one of the most studied polyether antibi-
otics and is fromone of the largest classes of bioactive
polyketide natural products. Biosynthesis of poly-
ethers involves polyketide chain formation on amodu-
lar polyketide synthase and a remarkable process of
oxidative cyclization. Monensin biosynthesis has
been proposed to involve a triepoxide intermediate
that undergoes regiospecific and stereospecific ring
opening and concomitant polyether ring formation,
but the enzymology has remained obscure. We show
here, from analysis of the polyketide products ofmuta-
tions in themonB genes of the monensin biosynthetic
gene cluster, together with homology modeling of the
Figure 7. Proposed Stepwise Cyclization in the Biosynthesis of
the Marine Toxin Brevetoxin, Catalyzed by a MonB-like Epoxide
Hydrolase
The boxed regions in each intermediate indicate the loci for the
successive action of an epoxide hydrolase.MonB enzymes by using the recently determined
structure of limonene epoxide hydrolase as a struc-
tural template, that the MonB enzymes, previously ten-
tatively assigned as isomerases involved in altering
the configuration of the initially formed polyketide,
are the key epoxide hydrolase/cyclase enzymes in
monensin biosynthesis. Based on this analysis,
MonB-like enzymesmay also be involved in the forma-
tion of the spectacular ladder polyether structures of
marine toxins such as brevetoxin. These insights
open the way to a complete deconvolution of the enzy-
mology of polyether biosynthesis andwill facilitate the
engineering of polyether biosynthetic pathways to
produce altered bioactive products.
Experimental Procedures
Culture Conditions
Seed cultures of wild-type and monensin-overproducing strains of
Streptomyces cinnamonensis and monB-deficient mutants of these
strains were grown in tryptic soy broth medium in flasks fitted with
springs at 30ºC and 200 rpm for 24 hr. These cultures (2.5 ml) were
then used to inoculate 25 ml of either a proprietary germinative me-
dium (I. Agayn, personal communication) or SM16-1 medium [9] in
a 250 ml Erlenmeyer flask and were grown at 32ºC and 200 rpm for
24–48 hr. From these seed cultures, each 2.5 ml portion was used
to inoculate 40 ml of either an oil-based monensin production me-
dium or SM16-1 in a 250 ml Erlenmeyer flask. The cultures were
grown at 32ºC and 200 rpm for 12 days. The relative humidity was
maintained at 90%. Flasks were weighed before the start of fermen-
tation, and any loss by evaporation was compensated for with sterile
water.
Extraction and Purification of epi-Monensin A
The combined culture broth (1 liter) was centrifuged at 7500 rpm for
45 min, the supernatant was extracted three times with ethyl acetate
(800 ml), and the combined organic fractions were evaporated in
vacuo. The residue was redissolved in hexane and shaken vigor-
ously with an equal volume of methanol:water (75:25 v/v). This mix-
ture was then centrifuged at 75003 g for 30 min, and the methanolic
layer was removed. This was repeated twice with fresh methanol:
water. The combined methanolic fractions were evaporated in
vacuo and then lyophilized. The oily extract was dissolved in minimal
ethyl acetate and passed twice through a silica column (35 3
100 mm), eluting with ethyl acetate:methanol (95:5). The solvent
was removed in vacuo, and the residue was redissolved in minimal
ethyl acetate and loaded onto a silica column (353 110 mm) packed
in ethyl acetate (containing 5% methanol v/v):dichloromethane (2:1
v/v) and eluted with the same solvent mixture. Fractions were ana-
lyzed by LC-MS, and those containing the desired product were
combined and evaporated in vacuo. This sample was then further
purified through silica by using the same method as in the previous
step. The relevant fractions (from LC-MS analysis) were pooled, and
the solvent was removed. The sample was then redissolved in meth-
anol (1.5 ml) and purified by preparative HPLC by using a Phenom-
enex Luna 10 mm C18(2) reverse-phase column (2120 3 250 mm).
The solvent gradient used was from 80% methanol, 20% aqueous
ammonium acetate (20 mM) to 100% methanol over 30 min, at
a flow rate of 15 ml min21. Fractions were collected at 30 s intervals
and analyzed by LC-MS. The fractions containing pure epi-monen-
sin A were combined and evaporated as much as possible in vacuo
and lyophilized. The product was then desalted by using an Isolute
C18(EC) 500 mg cartridge (Jones Chromatography Ltd., Pontypridd,
UK), and the product was lyophilized to yield C-9-epi-monensin A
(w250 mg) as a white powder. Other metabolites were purified in
the same manner.
Epimerization of epi-Monensin A
A sample of epi-monensin A (w5–10 mg) was dissolved in acetonitrile
(1 ml). One drop of 48% aqueous hydrofluoric acid was added, and
the reaction mixture was stirred at room temperature for 2 hr. The
reaction mixture was adjusted to wpH 9 with aqueous sodium
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459hydroxide (1 M), and the acetonitrile was removed in vacuo. The
aqueous residue was extracted twice with ethyl acetate (1.5 ml),
the organic extracts were combined and dried over anhydrous
MgSO4, and the solvent was removed. The sample was dissolved
in HPLC-grade methanol (200 ml) and analyzed by LC-MS.
Cyclization of Intermediates Obtained from Cultures
of S. cinnamonensis monB Mutants
Shake cultures were grown in SM16-1 medium [9] from a tryptic soy
broth inoculum for 5 days at 30º and 200 rpm. The culture broth su-
pernatant (50 ml) was extracted twice with ethyl acetate (50 ml), and
the combined fractions were dried and then evaporated in vacuo.
The crude product was adsorbed to a plug of silica and eluted
with ethyl acetate, and the dried product was redissolved in metha-
nol. The extract was analyzed by LC-MS, and the early-eluting me-
tabolites were collected separately. These were dried, redissolved
in acetonitrile, and treated with hydrofluoric acid, as described for
the epimerization of epi-monensin A.
Mass Spectrometric Analysis of epi-Monensin A
Accurate mass analyses were performed on a BioApex II (4.7 Tesla)
Fourier-transform cyclotron resonance instrument (Bruker Dalton-
ics, Billerica, MA). Solutions were infused from the Analytica ESI
source at 100 ml min21. CID fragmentation was performed on the iso-
lated ions with CO2 as the collision gas.
Expression and Purification of MonBI from Recombinant
Escherichia coli
The monBI gene was amplified by PCR by using cosmid S23 encod-
ing part of the monensin gene cluster as template [20] and oligonu-
cleotide primers 50-monB3-NdeI (50-CGCATATGAACGAGTTCGCCC
GCAAG-30) and 30-MonB3-NotI (50-TAGCGGCCGCGCCGAGGACC
GTGAGAT-30), which introduced, respectively, an NdeI site at the
50 end and a NotI site at the 30 end. The purified fragment was cloned
in pUC18, excised as a NdeI-NotI fragment, and ligated into expres-
sion plasmid pET-20b(+) (Novagen), which had been cut with the
same enzymes. This gave plasmid pMonB3-20, encoding MonBI
with a C-terminal hexahistidine tag, housed in E. coli strain BL21-
CodonPlus (DE3)-RP (Stratagene). A single colony of this recombi-
nant strain was used to inoculate 10 ml LB medium supplemented
with glucose (1 g/liter), 50 mg/liter carbenicillin, and 34 mg/liter chlor-
amphenicol, and the culture was grown overnight at 30ºC, then used
as an inoculum for 1 liter LB medium supplemented as described
above. When the absorbance at 600 nm reached 0.8, IPTG was
added to 0.5 mM concentration, and induction was allowed to pro-
ceed for 3 hr. Cells were harvested by centrifugation at 5000 3 g
for 20 min at 4ºC to yield approximately 3 g wet weight of cells.
The cells were suspended in 600 mM potassium phosphate buffer
(pH 7.5), containing 400 mM NaCl, 5 mM imidazole, and 1 mM phe-
nylmethanesulphonyl fluoride, and disrupted by two successive
passages through a French pressure cell operated at 1000 psi.
Cell debris was removed by centrifugation, the cleared lysate was in-
cubated with 1 ml Ni-NTA resin (Qiagen), and the mixture was gently
agitated on a rotary shaker at 4ºC for 1 hr. The resin was packed into
a column, and, after washing with the same buffer, MonBI was
eluted by a linear gradient of increasing imidazole concentration
(up to 250 mM imidazole) in the same buffer, in 40 fractions each
of 5 ml, at 1 ml/min. The fractions containing essentially pure MonBI
were desalted on a small HiPrep column (Pharmacia Biotech), con-
centrated by using a spin concentrator (molecular weight Cut off of
5000 Da) (Millipore), and stored frozen at 280ºC.
Small-Angle X-Ray Scattering Analysis of MonBI Protein
Data were collected at Station 2.1, Synchrotron Radiation Source,
Daresbury Laboratory by using a 2D multiwire proportional counter
at sample-to-detector distances of 1.25 and 4.25 m. Data from
matching buffers (50 mM Tris-HCl buffer [pH 7.0] and 100 mM
NaCl) were collected and subtracted from the protein profiles.
MonB1 solutions at concentrations ranging from 4 to 10 mg/ml
and pH 4–8 were analyzed at 20ºC. The radius of gyration, Rg; the
maximum particle dimension, Dmax; and the intraparticle distance
distribution function, (p[r]), were calculated from the scattering
data by using the indirect Fourier transform method program
Gnom [33]. Molecular shapes were reconstructed from the scatter-ing profile (after merging high- and low-resolution data) by using the
ab initio procedure of simulating annealing with clustered spheres
representing amino acid residues (Gasbor versions 1.8 and 2.0)
[34]. Shape reconstruction results in a 3D arrangement of scattering
centers (spheres 3.5 A˚ in diameter) that reproduce the 1D scattering
curve in accordance with the experimental data. These are dis-
played by using the space fill option to produce the overall molecular
shape.
Similarity Search and Protein Modeling
The sequence of MonBI was compared with all protein sequences
deposited in SWISS-PROT by using the Blast v2.0 program [35]. A
PSI-BLAST search produced an alignment between MonBI and
homologous proteins that highlights conserved residues in the ep-
oxide hydrolase family. Homologous proteins with known structure
were identified by using the FUGUE [14] homology recognition
server. FUGUE searches for homologs in the structural profile library
derived from the structure-based alignments in the HOMSTRAD da-
tabase [36] and, using the environment-specific substitution tables,
automatically generates the best alignments for the top hits. The
alignment produced by FUGUE for the highest-scoring hit was for-
matted with JOY [37] and was analyzed visually to highlight the con-
servation of structurally and functionally important residues. The
model of MonBI was constructed with MODELLER [38]. A final
energy and structure minimization was done by using the SYBYL
(Tripos, Inc., St. Louis, MO) force field. The model was validated
with PROCHECK [39], VERIFY3D [40], JOY, and by visual inspection
with 3D graphics software. Computer renderings of structures were
created by using the program PyMOL [41].
Supplemental Data
Supplemental Data including LC-MS, NMR data for epi-monensin,
details of protein expression and purification, and SAXs data for
MonBI are available at http://www.chembiol.com/cgi/content/full/
13/4/453/DC1/.
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